Global Expansion BD's international growth including expansion into Saudi Arabia and Asia creates new market access for Bard's vascular, urology, oncology and surgical devices through established BD channels, regulatory, and distribution networks.

Urology Synergy The BD Elyra Thulium Laser System launch signals a strategic complement to Bard's urology portfolio, enabling bundled offerings and joint go-to-market strategies for kidney stone care and endourology.

Single Use Value Bard's focus on single-patient-use products aligns with hospital cost containment; leverage BD's procurement and supply chain to drive standardized, sterile single-use devices across key procedural areas.

Digital Health Enablement Bard's tech stack and BD's ongoing digital health transformation open opportunities for data-driven procurement, utilization analytics, and integrated connected-care solutions across hospital networks.

Enterprise Growth With Bard's sizeable market footprint and BD's scale, target large hospital systems with enterprise contracts, multi-year procurement programs, and international supply agreements to drive broad adoption.